ArticleFrontiers in neuroscience2026
Amino acid profiles and clinical phenotypes in young children with autism spectrum disorder.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: In 394 children with autism spectrum disorder (ASD), we investigated the association between plasma amino acid (AA) concentrations and clinical phenotypes. Methods: Multivariable logistic regression models were used to evaluate the associations between 22 AAs and clinical features, reporting odds ratios. Results: The median age at diagnosis was 3.5 years (interquartile range: 2.8-4.6 years) for boys and 3.1 years (interquartile range: 2.3-3.8 years) for girls; 81.5% of the participants were boys. A 25-unit increase in cystine concentration was associated with stereotypies (OR = 2.07), hyperactivity (OR = 1.79), and aggressive behavior (OR = 2.13), suggesting a potential role of oxidative stress in these phenotypes. Similarly, a 25-unit increase in taurine levels was associated with hyperactivity (OR = 1.24) and intellectual disability (OR = 1.38), consistent with oxidative imbalance. Higher arginine levels appeared to have a protective effect against hyperactivity (OR = 0.70), indicating a potential role in ammonia detoxification. Increased glutamine and tyrosine levels were associated with ORs < 1 for stereotypies, supporting potential neuroprotective roles. Discussion: These findings suggest oxidative stress, urea cycle dysfunction, and altered neurotransmission may contribute to the pathophysiology of ASD and related clinical phenotypes in young children, warranting further investigation to inform the development of personalized clinical and nutritional interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.